<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00160758</url>
  </required_header>
  <id_info>
    <org_study_id>214-1999</org_study_id>
    <nct_id>NCT00160758</nct_id>
  </id_info>
  <brief_title>Physical Characteristics of Retrieved Massive Allografts</brief_title>
  <official_title>Physical Characteristics of Retrieved Massive Allografts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This purpose of this study is to measure the strength of tissue allografts that have been in&#xD;
      the body various lengths of time.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Allograft bone is the primary source of graft material for large skeletal defects resulting&#xD;
      from trauma, disease, oncological resection, or reconstruction of failed total joint&#xD;
      arthroplasties. The physical characteristics of such grafts after various intervals of&#xD;
      remodeling and incorporation in vivo have never been studied.&#xD;
&#xD;
      The purpose of this study is to obtain tissue from allografts retrieved at autopsy, at&#xD;
      amputation for oncological complications and from patients undergoing revision procedures for&#xD;
      failed allograft transplantation. We will evaluate the mechanical properties,&#xD;
      histomorphometric indices and presence of microfractures.&#xD;
&#xD;
      Our hypotheses are:&#xD;
&#xD;
        -  histomorphometric parameters of porosity and microfracture density will predict&#xD;
           allograft strength,&#xD;
&#xD;
        -  microfracture density will be correlated with time in vivo and allograft strength,&#xD;
&#xD;
        -  the rate of host-allograft nonunion and fracture will correlate with radiation therapy&#xD;
           and chemotherapy.&#xD;
&#xD;
      The retrieved tissue will be processed using standard undecalcified histology and&#xD;
      quantitatively assessed for degree of incorporation, allograft porosity, and microfracture&#xD;
      density. The biomechanical characteristics of the bulk allograft and allograft-host junction&#xD;
      will be quantified and compared to allograft bone prior to transplantation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 1999</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">18</enrollment>
  <condition>Bone Cancer</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>retrieve massive allograft</intervention_name>
    <description>Allograft constructs removed because of infection or cancer complications will be retained for biomechanical testing</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Orthopaedic clinic&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  failed allograft bone&#xD;
&#xD;
          -  removal of allograft due to oncological complications&#xD;
&#xD;
          -  amputation due to oncological complications&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  none&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark T. Scarborough, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UF Orthopaedics and Sports Medicine Institute</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <study_first_submitted>September 8, 2005</study_first_submitted>
  <study_first_submitted_qc>September 11, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>October 26, 2012</last_update_submitted>
  <last_update_submitted_qc>October 26, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

